Citations

Showing 10 of 108104 citations.

Utilization of Vascular Endothelial Growth Factor-C156S in Therapeutic Lymphangiogenesis: A Systematic Review
Forte, Antonio J. , Huayllani, MarĂ­a T. , Anastasiadis, Panos Z. , McLaughlin, Sarah A. , Boczar, Daniel , Forte, Antonio Jorge

Mayo Clinic

Lymphatic Research and Biology | May 3, 2022 | Volume: 20 | Issue: 6 | Pages: 580-584

10.1089/lrb.2020.0012 | PMID 35501971 Get It

Background: Vascular endothelial growth factor (VEGF) C156S is an engineering variant of VEGF-C that has the potential to promote lymphangiogenesis, activating on VEGF receptor (VEGFR) 3, without promoting angiogenesis (i.e., not acting on VEGFR-2). We conducted a systematic review of publications assessing the use of this growth factor in lymphedema treatment. We hypothesized that VEGF-C156S specificity for VEGFR-3 was an important differential for the lymphangiogenesis promoted by it. Methods and Results: We conducted a comprehensive systematic review of the published literature on PubMed/Medline, Embase, and Cochrane Clinical Answers. Eligibility criteria included articles reporting data on the use of VEGF-C156S in lymphedema treatment. We excluded articles that investigated physiology action of VEGF-C156S and articles that focused on other therapies. From 304 potential articles found in the literature, four studies fulfilled the study eligibility criteria. To date, all studies about this growth factor have been experimental. The effect of VEGF-C156 on lymph node transfer was investigated in half of the experiments. Interestingly, delivery of VEGF-C156S was mostly performed through viral gene transfer, but injection (subcutaneously or intravenously) of it as a protein (liposomal or nonliposomal) was also investigated by one author to assess drug bioavailability. Conclusions: Although authors reported promotion of lymphangiogenesis, VEGF-C156S was correlated with lymphatic hyperplasia or nonstatistically significant lymphangiogenesis compared with controls. Scientific evidence about the use of VEGF-C156S in lymphedema treatment is still limited. However, authors have shown that its lymphangiogenic effect is inferior to VEGF-C.
Kisspeptin Attenuates Airway Smooth Muscle Cell Migration by Regulating Rho GTPase Signaling Pathway
Balraj, Premanand , Ambhore, Nilesh Sudhakar , Borkar, Niyati A. , Pabelick, C.M., Prakash, Y.S., Venkatachalem, S., Pabelick, C.M., Prakash, Y. S.

Mayo Clinic

A29. CLINICAL AND TRANSLATIONAL STUDIES OF ASTHMA | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A1229-A1229

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1229 Get It

Effect of Home-Based Rehabilitation with Health Coaching on Chronic Obstructive Pulmonary Disease Outcomes: A Randomized Study
Benzo, Roberto, Hoult, J.P., McEvoy, Carmen, Clark, Mike , Benzo, M.V., Johnson, Maja, Novotny, Paul, Mcevoy, C.E.

Mayo Clinic

A16. PULMONARY REHABILITATION: TRANSFORMING OUR PRACTICE IN 2022 | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A1027-A1027

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1027 Get It

Insights from the ADVOCATE Study: Respiratory Tract Involvement in Patients with ANCA-Associated Vasculitis in a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Avacopan
Merkel, P.A., Specks, Ulrich , Jayne, David , Merkel, P.A.

Mayo Clinic

C93. CLINICAL TRIALS IN CHRONIC LUNG DISEASE | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4780-A4780

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4780 Get It

Correlation of Patient-Reported Outcomes with Disease Subtype and Functional Severity in Fibrotic Interstitial Lung Disease
Duke, J.D., Roy, M., Hoult, Johanna, Benzo, R., Moua, T., Duke, J.D., Moua, T.

Mayo Clinic

D21. RISK FACTORS AND PREDICTORS IN CRITICAL ILLNESS AND CHRONIC RESPIRATORY DISEASES | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A5091-A5091

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5091 Get It

Accessibility of Cardiothoracic Surgeons to the Medicare Population: A State-by-State Analysis
Arif, M. , Afzal, D., Fatima, S., Khurana, Ashwani, Khurana, A.

Mayo Clinic

C36. HOT TOPICS IN BEHAVIORAL SCIENCES AND HEALTH SERVICES RESEARCH | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4004-A4004

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4004 Get It

Human Platelet Derived Exosome Product Attenuates Cigarette Smoke Induced Murine Emphysema
Wang, S., Xuan, W., Peterson, T., Stalboerger, P., Behfar, A., Vassallo, R., Wang, S., Vassallo, R.

Mayo Clinic

A17. COPD: SINGLE CELL RNA SEQUENCING, EPIGENETICS, MODELS, AND MACROPHAGES | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A1042-A1042

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1042 Get It

Engagement in Health Coaching and Self-Management Abilities in COPD
Benzo, M.V., Kelpin, Sydney S., Werneburg, Brooke L., Clark, Matthew M. , Novotny, Paul, Hoult, J.P., Benzo, Roberto

Mayo Clinic

C102. USING ANALOG OR TECHNOLOGY TOOLS TO EVALUATE AND INTERVENE TO IMPROVE HEALTHCARE DELIVERY | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4859-A4859

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4859 Get It

One Size Does Not Fit All: Adding Granularity to COPD Self-Management
Benzo, M.V. , Novotny, P., Benzo, Roberto

Mayo Clinic

C102. USING ANALOG OR TECHNOLOGY TOOLS TO EVALUATE AND INTERVENE TO IMPROVE HEALTHCARE DELIVERY | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4858-A4858

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4858 Get It

Lifestyle Intervention Targeting Weight Loss to Reduce Dyspnea in Chronic Lung Disease
Benzo, M.V. , Roy, M., Benzo, Roberto

Mayo Clinic

A93. QUALITY OF CARE, HEALTH DISPARITIES, AND HEALTHCARE UTILIZATION AMONG PATIENTS WITH ASTHMA OR COPD | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A2124-A2124

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2124 Get It